Literature DB >> 30006034

Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study.

Claudio Liguori1, Alessandro Stefani2, Roberta Ruffini3, Nicola Biagio Mercuri4, Mariangela Pierantozzi2.   

Abstract

Entities:  

Keywords:  Daytime sleepiness; Parkinson's disease; Rasagiline; Safinamide; Scales; Sleep

Mesh：

Substances：

Year:  2018        PMID： 30006034     DOI： 10.1016/j.parkreldis.2018.06.033

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  13 in total

1.  Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson's disease population: an open-label, levodopa add-on study.

Authors:  Bruno Bergmans; Philip Bourgeois; Patrick Cras; Sophie Dethy; Nina De Klippel; Gianni Franco; Gaëtan Garraux; Karine Geens; Philippe Jacquerye; Anne Jeanjean; Frédéric Supiot; Chris Van der Linden; Claude Krygier
Journal:  Acta Neurol Belg       Date:  2022-10-06       Impact factor: 2.471

2.  Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson's disease: A systematic review.

Authors:  Takashi Tsuboi; Yuki Satake; Keita Hiraga; Katsunori Yokoi; Makoto Hattori; Masashi Suzuki; Kazuhiro Hara; Adolfo Ramirez-Zamora; Michael S Okun; Masahisa Katsuno
Journal:  NPJ Parkinsons Dis       Date:  2022-06-13

3.  Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study.

Authors:  Gloria Martí-Andrés; Rayco Jiménez-Bolaños; José Matias Arbelo-González; Javier Pagonabarraga; Carmen Duran-Herrera; Rafael Valenti-Azcarate; Mª Rosario Luquin
Journal:  Brain Sci       Date:  2019-10-11

4.  SURINPARK: Safinamide for Urinary Symptoms in Parkinson's Disease.

Authors:  Ana Gómez-López; Arantxa Sánchez-Sánchez; Elena Natera-Villalba; Victoria Ros-Castelló; Álvaro Beltrán-Corbellini; Samira Fanjul-Arbós; Isabel Pareés Moreno; José Luis López-Sendon Moreno; Juan Carlos Martínez Castrillo; Araceli Alonso-Canovas
Journal:  Brain Sci       Date:  2021-01-06

5.  Prescription Pattern of Monoamine Oxidase B Inhibitors Combined with Levodopa: A Retrospective Observational Analysis of Italian Healthcare Administrative Databases.

Authors:  Giulia Ronconi; Silvia Calabria; Carlo Piccinni; Letizia Dondi; Antonella Pedrini; Immacolata Esposito; Alice Addesi; Luisa Sambati; Nello Martini
Journal:  Drugs Real World Outcomes       Date:  2022-06-13

Review 6.  The Current Evidence for the Use of Safinamide for the Treatment of Parkinson's Disease.

Authors:  Giovanni Abbruzzese; Paolo Barone; Leonardo Lopiano; Fabrizio Stocchi
Journal:  Drug Des Devel Ther       Date:  2021-06-10       Impact factor: 4.162

Review 7.  A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice.

Authors:  Javier Pagonabarraga; José Matías Arbelo; Francisco Grandas; Maria-Rosario Luquin; Pablo Martínez Martín; Mari Cruz Rodríguez-Oroz; Francesc Valldeoriola; Jaime Kulisevsky
Journal:  Brain Sci       Date:  2020-03-18

8.  Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study.

Authors:  Diego Santos García; Carmen Labandeira Guerra; Rosa Yáñez Baña; Maria Icíar Cimas Hernando; Iria Cabo López; Jose Manuel Paz Gonález; Maria Gemma Alonso Losada; María José González Palmás; Cristina Martínez Miró
Journal:  Brain Sci       Date:  2021-03-02

9.  Effects of safinamide on pain in patients with fluctuating Parkinson's disease.

Authors:  Sotirios Grigoriou; Pablo Martínez-Martín; K Ray Chaudhuri; Katarina Rukavina; Valentina Leta; Denise Hausbrand; Björn Falkenburger; Per Odin; Heinz Reichmann
Journal:  Brain Behav       Date:  2021-09-03       Impact factor: 2.708

Review 10.  Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future.

Authors:  Yu-Yan Tan; Peter Jenner; Sheng-Di Chen
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.